Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Insider Transactions
  • inderesTV
  • Portfolio
  • Forum
  • Premium
  • Femme
  • Learn
    • Investing School
    • Q&A
    • Analysis School
  • About Us
    • Our Coverage
    • Team
Log in to your Inderes Free account to see all free content on this page.
Create account

Cyxone

Less than 1K followers
All
Research
Press releases
ShowingAll content types
Regulatory press release8/26/2024, 12:19 PM

Cyxone AB announces last day of trading in BTA

Cyxone
Regulatory press release8/16/2024, 6:59 AM

Cyxone AB publishes outcome of rights issue

Cyxone
Regulatory press release8/1/2024, 6:45 AM

The subscription period in Cyxone's rights issue starts today

Cyxone

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio
Create account
Regulatory press release7/31/2024, 6:45 AM

Cyxone AB publishes investment memorandum

Cyxone
Regulatory press release7/23/2024, 6:30 AM

Cyxone: The board decides on a rights issue of a maximum of approximately SEK 23 million to finance continued development of rabeximod and T20K

Cyxone
Press release7/15/2024, 6:42 AM

Cyxone provides an update on its research and development program

Cyxone
Regulatory press release4/22/2024, 8:02 AM

Kjell Stenberg new CEO in Cyxone AB

Cyxone
Press release3/28/2024, 10:52 AM

BioStock: Cyxone comments on the clinical collaboration in the UK

Cyxone
Press release3/25/2024, 12:44 PM

Cyxone enters important research collaboration

Cyxone
Press release3/5/2024, 8:42 AM

BioStock: Cyxone's CEO gives a status update

Cyxone
Press release1/17/2024, 7:45 AM

BioStock: Cyxone identifies target protein for rabeximod

Cyxone
Press release1/15/2024, 9:01 AM

Cyxone reaches important milestone regarding mechanism of action

Cyxone
Press release11/20/2023, 8:22 AM

Cyxone welcomes a renewed engagement by Professor Rikard Holmdahl as Scientific Advisor

Cyxone
Regulatory press release10/27/2023, 6:29 AM

Cyxone: Interim Report 1 January to 30 September 2023

Cyxone
Regulatory press release10/9/2023, 6:38 AM

Cyxone receives Intention to Grant from the European Patent Office for a unitary patent of T20K

Cyxone
Press release9/27/2023, 7:30 AM

BioStock Investor Meeting: Cyxone

Cyxone
Regulatory press release8/30/2023, 6:32 AM

Cyxone: Interim Report 1 January to 30 June 2023

Cyxone
Regulatory press release8/29/2023, 5:03 PM

Cyxone revises strategy for commercial alignment targeting valuable market opportunities

Cyxone
Regulatory press release6/15/2023, 6:30 AM

Cyxone appoints Urban Ottosson as new CFO

Cyxone
Press release5/31/2023, 12:00 PM

Cyxone receives Intention to Grant from the European Patent Office for the divisional patent of T20K

Cyxone
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.